A new drug regulation was recently announced in Canada, this time controlling the packaging. That’s the Plain Language Labelling Initiative, which will be an overhaul of how drugs are described on their boxes and bottles. This new initiative aims at altering guidelines for better clarity. While pharmaceutical quality control can ensure that the contents of a package provide exactly the results they’re supposed to, it’s of equal importance to make sure healthcare professionals and consumers are also picking the right products. That means universal standards to prevent confusion between very similarly named or packaged drugs, oversight that is expected to.. READ MORE »
report by Rx&D, the Canadian association of pharmaceutical companies, confirms an ongoing trend of under-reporting of pharmaceutical innovation investment by government bodies. The report, released in May, shows a consistent 34% under-reporting rate over the past three years. Pharmaceutical research investment in Canada is tracked by two government agencies, Statistics Canada and PRPMB (Patented Medicine Prices Review Board). The agencies work independently because they are gathering information for different mandates, and use separate methodology, but both produce similar data. However, Rx&D, which is also responsible for considerable self-regulation in the pharmaceutical industry, decided to track their own investments through studies.. READ MORE »
A recent study of 255 physicians in Canada, the United States and France highlights the important impact of pharmaceutical sales on doctors’ decisions and physicians’ reliance on sales representatives’ willingness to educate them on the full effects of the drugs they are selling. Researchers, who looked at doctors in Montreal, Vancouver, Sacramento and Toulouse, were interested in finding out how willing sales professionals were to discuss side effects of drugs. What they found was that on average, 66% of the Canadian physicians reported that they received no information about adverse side effects whatsoever. Globally, they found that only 6% of.. READ MORE »
Last week we covered a generic drug pricing deal that will affect most of Canada. This week we’re coming back to Ontario to take a closer look at the local impact of the laws on generics. While generic drugs are typically sold at lower prices than the brand name option, for pharmacies, stocking them is more than a matter of choice. In the past, the cost born by the retailer was boosted by two factors: a 13% higher provincial subsidy, greater than the one for branded drugs, and the ability to get a rebate from the manufacturing company of the.. READ MORE »
One of the current challenges in the pharmaceutical industry is the role of generic drugs. This January, several provinces and territories have joined together to put their combined weight to play when it comes to negotiating on generic drug pricing. Generics drugs are an important part of pharmaceutical research, manufacturing and sales. A generic drug is a non-branded version of a medication whose effects are considered comparable to the branded version. They include anything from store brand aspirin to prescription-only pain killers. Generics are cheaper than non-generic drugs and they usually only differ in small matters like flavouring. No matter.. READ MORE »
This week, we’ll look at two big conferences that may be affecting the future policy for everything from pharmaceutical research and development funding to drug sales regulations. BIO, a large, international conference, and the Quebec-based Assises nationales sur la recherche et l’innovation. As of today, delegates from the Ontario government are meeting at the 2013 BIO conference in Chicago. An annual event spanning the participation of 65 countries, BIO is big news for anyone working or studying to be part of pharmaceutical manufacturing and research. It’s a place where pharmaceutical and medical research-boosting strategy is discussed; business and government connect;.. READ MORE »
According to the 2011 study by the CACDS (Canadian Association of Chain Drug Stores), 42% of pharmacies in Canada offer “expanded services”. Broadly speaking, this means that pharmacies within the community offer other healthcare services in addition to dispensing prescriptions. This might be anything from weight management assistance to services for patients with depression and chronic illnesses, or it might even include specialty services like home visits or geriatric care. Among the most popular expanded services are smoking cessation assistance, diabetes maintenance and medication management. Expanded services are more common in pharmacies located in urban areas than in rural areas.. READ MORE »
Contact us directly or provide your information for a call back.
885 Sheppard Avenue West
Toronto, Ontario
M3H 2T4, Canada
Mon-Fri 8:30am – 5:00pm
Sat – by appointment only
2960 Drew Road, Unit 140
Mississauga, Ontario
L4T 0A5, Canada
Telephone: 416-502-2277
Toll Free: 1-855-502-2288
Email: info@aaps.ca
Contact us directly or provide your information for a call back.
AAPS College graduates thrive with leading employers in health, science, and technology, showing how our programs translate into real careers and success.
